Previous 10 | Next 10 |
2023-08-08 10:34:31 ET Summary Viatris Inc. announced its Q2 2023 earnings yesterday. Total net sales were $3.9bn, and free cash flow $447m. While like-for-like product sales grew year-on-year, EBITDA and FCF declined significantly, owing to increased SG&A and R&D spending...
2023-08-07 12:13:10 ET Viatris Inc. (VTRS) Q2 2023 Earnings Call Transcript August 07, 2023 08:30 AM ET Company Participants William Szablewski - Head of Global Capital Markets Scott Smith - Chief Executive Officer Rajiv Malik - President Sanjeev Narula - Chi...
2023-08-07 08:07:17 ET More on Viatris Viatris: Currently Appealing Only To Income-Focused Investors Viatris: Developing Into A Fantastic Investment Opportunity Despite Its Valuation, Viatris Is Still A Hold Viatris posts first topline beat in over a year as ...
2023-08-07 07:43:11 ET More on Viatris Viatris: Currently Appealing Only To Income-Focused Investors Viatris: Developing Into A Fantastic Investment Opportunity Despite Its Valuation, Viatris Is Still A Hold Viatris: Won't Take Much To Move The Needle ...
2023-08-07 07:04:57 ET Viatris press release ( NASDAQ: VTRS ): Q2 GAAP EPS of $0.22 beats by $0.02 . Revenue of $3.92B (-4.9% Y/Y) beats by $60M . Adjusted EBITDA of $1.31 Billion; U.S. GAAP Net Cash Provided by Operating Activities of $515 Million; a...
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1] PR Newswire Reports Total Revenues of $3.92 Billion ; U.S. GAAP Net Earnings of $264 Million ; Adjusted EBITDA of $1.31 Billion ; U.S....
Viatris and Mapi Pharma Announce FDA Acceptance of New Drug Application Filing for GA Depot for the Treatment of Relapsing Forms of Multiple Sclerosis PR Newswire FDA assigns PDUFA target action date of March 8, 2024 New Drug Application supported by positive Phase...
2023-08-06 08:01:00 ET The second week of August promises to be an eventful one for investors as a slew of major companies is set to report quarterly results. Among the headliners, Disney ( NYSE: DIS ) is prehaps the most well-known company due to report. The schedule also incl...
2023-08-04 08:20:00 ET Especially if you're living on a fixed income, being able to bring in even $1,500 in extra money each year via dividends can be a big change for the better. But it's often difficult to figure out which dividend stock has what it takes to keep paying out for years and ...
Viatris Announces Launch of Breyna™ (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort® for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva PR Newswire Lau...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...